ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,807Medicare Part D Prescriptions Filled, Including Refills

Rank: 598 out of 4853

$544K Total Retail Price of All Prescriptions

Rank: 885 out of 4853

540 Patients Receiving at Least One Drug in Part D
86% Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Texas
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

3% of this provider’s 540 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

17% of this provider’s 540 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 504 441 93 1 1
HYDROCODONE-ACETAMINOPHEN 410 245 84 S3 2 3
AMLODIPINE BESYLATE 383 359 72 3 5
SIMVASTATIN 375 354 83 4 4
LISINOPRIL 352 328 80 5 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 212 181 48 6 21
OMEPRAZOLE 203 185 48 7 8
PRAVASTATIN SODIUM 194 173 43 8 10
CITALOPRAM HBR 192 152 37 9 26
LOSARTAN POTASSIUM 186 160 35 10 18
GABAPENTIN 172 116 32 11 13
FUROSEMIDE 159 143 40 12 9
METFORMIN HCL 155 150* 33 13 6
ATORVASTATIN CALCIUM 155 113 39 13 7
PANTOPRAZOLE SODIUM 150 108 33 15 31
TRAZODONE HCL 150 104 28 15 40
TRAMADOL HCL 148 110 37 17 14
FLUTICASONE PROPIONATE 140 104 47 18 33
METOPROLOL TARTRATE 137 123 37 19 11
TAMSULOSIN HCL 133 128* 26 20 28
HYDROCHLOROTHIAZIDE 132 117 34 21 12
ZOLPIDEM TARTRATE 132 114 31 21 22
CLONAZEPAM 129 65 20 B 23 52
ALPRAZOLAM 128 104 27 B 24 17
CARVEDILOL 123 98 24 25 24
MONTELUKAST SODIUM 112 71 16 26 39
SERTRALINE HCL 111 106* 24 27 25
MELOXICAM 109 90 36 28 27
CLOPIDOGREL 103 80 22 29 19
POTASSIUM CHLORIDE 103 79 26 29 16
METOPROLOL SUCCINATE 95 90* 24 31 15
SPIRONOLACTONE 94 77 19 32 76
METFORMIN HCL ER 91 86* 23 33 47
LOVASTATIN 90 85* 16 34 42
CRESTOR 88 54 16 35 23
ROPINIROLE HCL 88 83* 19 35 108
WARFARIN SODIUM 88 83* 20 35 29
AMITRIPTYLINE HCL 86 66 19 R 38 75
CYCLOBENZAPRINE HCL 82 38 20 R 39 68
ATENOLOL 79 74* 22 40 32
VENLAFAXINE HCL ER 78 40 14 41 114
DONEPEZIL HCL 75 75 12 42 35
NAMENDA 74 <11 <11 43 34
TRIAMTERENE-HCTZ 71 71 13 44 78
NEXIUM 68 50 13 45 20
VALSARTAN-HYDROCHLOROTHIAZIDE 67 62* 13 46 66
LOSARTAN-HYDROCHLOROTHIAZIDE 66 61* 12 47 44
BENAZEPRIL HCL 65 60* 13 48 74
ALLOPURINOL 63 50 13 49 38
LORAZEPAM 63 39 16 B 49 43
GLIPIZIDE ER 63 63 11 49 96
GLIPIZIDE 60 55* 12 52 46
TRIAMCINOLONE ACETONIDE 55 50* 29 53 117
FENOFIBRATE* 54 <11 <11 54 56
FENOFIBRATE* 53 <11 <11 55 56
TEMAZEPAM 52 41 15 B 56 82
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 6, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.